Publications
366
Citations
11,208
Est. group size
~7
Recurring co-author estimate
Active years
27
Publishing since 2000
Typically publishes in teams of ~10 · 12% small-team papers (≤3 authors) · across 62 venues
- Antihypertensive Dosing During Mavacamten Therapy for Obstructive Hypertrophic Cardiomyopathy
Journal of Cardiac Failure - Intersections · 2026
- 26-A-11567-ACC MAVACAMTEN DEMONSTRATES CLINICAL AND HEMODYNAMIC BENEFITS IN SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY WITH ONLY PROVOCABLE OUTFLOW GRADIENTS: REAL-WORLD EXPERIENCE FROM MARVEL-HCM
Journal of the American College of Cardiology · 2026
- 26-A-11568-ACC EFFECTIVENESS AND SAFETY OF MAVACAMTEN IN A COHORT WITH HIGH BACKGROUND PREVALENCE OF ATRIAL FIBRILLATION: REAL-WORLD EXPERIENCE FROM MARVEL-HCM
Journal of the American College of Cardiology · 2026
- A randomized study of digital versus genetic counselor return of actionable genetic research results to biobank participants (RESPECT3 study)
BMC Medical Ethics · 2026
- Ventricular Arrhythmia Ablation in Inherited Cardiomyopathy: Phenotype Variability and Outcomes Based on Functional Genotypes
Journal of the American Heart Association · 2026
- Common-variant and rare-variant genetic architecture of heart failure across the allele-frequency spectrum
Nature Genetics · 2025
- Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial
Circulation · 2025
- Long-Term Real-World Outcomes of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy up to 108 Weeks
Journal of Clinical Medicine · 2025
- Pathophysiology and Therapeutic Needs in Nonobstructive Hypertrophic Cardiomyopathy
JACC Heart Failure · 2025
- Polygenic Background and Penetrance of Pathogenic Variants in Hypertrophic and Dilated Cardiomyopathies
JAMA Cardiology · 2025
- Prognostic Value of Compact Myocardial Thinning in Patients With Left Ventricular Noncompaction
The American Journal of Cardiology · 2025
- Desmoplakin cardiomyopathy: recent updates in natural history and management
Current Opinion in Cardiology · 2025
- Hypertension in Patients With Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten
JACC Heart Failure · 2025
- CYP450 activity, drug interactions, and genetic polymorphisms: clinical relevance for the new selective cardiac myosin inhibitors
Expert Opinion on Drug Safety · 2025
- Sex Differences In Characteristics Of Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Initiated On Mavacamten
Journal of Cardiac Failure · 2025
- Circulation×61
- Journal of the American College of Cardiology×53
- Journal of Cardiac Failure×25
- Circulation Genomic and Precision Medicine×15
- JACC Heart Failure×15
- Caroline Coats
Medicine · University of Michigan
- Sara Saberi
Medicine · University of Michigan
- Michael A. Fifer
Medicine · University of Michigan
- Albree Tower‐Rader
Medicine · University of Michigan
- Adam Helms
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile